Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GlaxoSmithKline discloses SIRT1 activators

June 2, 2016

Audentes gene therapy AT-342 granted U.S. orphan status for Crigler Najjar syndrome

June 2, 2016

FDA accepts for filing Radius Health's NDA for abaloparatide-SC

June 1, 2016

Amicus's migalastat hydrochloride obtains first approval in Europe

June 1, 2016

Studies with CM-4620 in pancreatitis models suggest CRAC inhibition is beneficial

June 1, 2016

L-Citrulline safe but has rapid clearance in patients with sickle cell disease

June 1, 2016

Saxagliptin/dapagliflozin receives positive opinion in E.U.

May 30, 2016

European Commission approves Strimvelis for ADA-SCID

May 30, 2016

Biallelic mutations in PPA2 are associated with mitochondrial dysfunction

May 30, 2016

First viable murine model of cblC type CMAH reported

May 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...